Intelligence Platform
Patents
Browse 774 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11382897
Therapeutic combination for treatment of cerebellar ataxia
granted patentUS 11376221
Polymer particles for neutrophil injury
granted patentUS 11369683
Systems and methods for targeted imaging and ablation of cardiac cells
granted patentUS 11358965
EGFR dimer disruptors and use of the same
granted patentUS 11319302
PRC1 inhibitors and methods of treatment therewith
granted patentUS 11311624
Inhibitors of MEK/PI3K, JAK/MEK, JAK/PI3K/mTOR and MEK/PI3K/mTOR biological pathways and m
granted patentUS 11267822
BET bromodomain protein degraders with cleavable linkers
granted patentUS 11260083
Compositions and methods for treating and preventing graft versus host disease
granted patentUS 11248022
Glypican-3 peptide reagents and methods
granted patentUS 11235066
Micelles and methods
granted patentUS 11236044
Selective inhibitors of 12(S)-lipoxygenase (12-LOX) and methods for use of the same
granted patentUS 11224584
Sleep apnea treatment
granted patentUS 11219673
Compositions and methods for delivery of biomacromolecule agents
granted patentUS 11220479
Glucosylceramide synthase inhibitors and therapeutic methods using the same
granted patentUS 11214603
C3D cellular and acellular vaccines for the prevention and treatment of cancer
granted patentUS 11214567
Small molecule inhibitors of MYC and uses thereof
granted patentUS 11198724
Treatment of staphylococcal disorders
granted patentUS 11192898
MDM2 protein degraders
granted patentUS 11173207
Adjuvant compositions
granted patentUS 11168071
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
granted patentUS 11168082
Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitors
granted patentUS 11148998
Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof
granted patentUS 11147885
ASH1L inhibitors and methods of treatment therewith
granted patentUS 11116825
Cancer vaccine compositions and methods of using the same
granted